YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB26FUWEU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,567
Award facts
- Contract value 100% obligated
- $5,567.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The contract utilizes firm fixed-price pricing with an ultimate completion date of November 13, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group holds a single-award IDC designated as contract SPE2DR, awarded on November 13, 2025, with a ceiling value of $500 million and an ultimate completion date of December 31, 2036. This contract positions the company as a critical pharmaceutical supplier within the Department of Defense's global military healthcare supply chain, authorized to provide firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables. The PPV-G GEN V program represents a $30.3 billion acquisition strategy, with DMS Pharmaceutical Group serving as one of multiple regional prime vendor contractors supporting recurring medical supply needs across Department of Defense healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FUWEU?
SPE2DB26FUWEU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FUWEU worth?
The government has obligated $5,567 on SPE2DB26FUWEU.
Is contract SPE2DB26FUWEU an order under another contract?
Yes. SPE2DB26FUWEU is a delivery order under SPE2DB25D9318, an indefinite delivery contract.
Was contract SPE2DB26FUWEU competed?
The extent of competition for SPE2DB26FUWEU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award